Target intelligence / Profile preview

Inositol 1,4,5-trisphosphate receptor 1 (IP3R1)

Target
IP3R1
Molecular classification
Ion channel, Ligand-gated calcium channel, Intracellular receptor, Receptor
01

Overview

The Inositol 1,4,5-trisphosphate receptor 1 is a tetrameric intracellular Ca2+ channel located primarily on the membrane of the endoplasmic reticulum. Activated by binding inositol 1,4,5-trisphosphate (IP3), it enables Ca2+ release into the cytoplasm in response to diverse extracellular signals. IP3R1 channels are crucial for the spatiotemporal organization of intracellular Ca2+ signals that drive cellular responses such as apoptosis, autophagy, and proliferation. Structurally, IP3R1 consists of a large cytoplasmic domain (including the ligand-binding site), a transmembrane ion-conducting pore, and associated regulatory motifs that interact with proteins (e.g. Beclin 1, Bcl-2). Three major subtypes exist (IP3R1, IP3R2, IP3R3), each encoded by distinct genes. IP3R1 is highly expressed in nervous tissue and plays a key role in neuronal calcium signaling, as well as mediating crosstalk between cellular signaling pathways. Disruption of IP3R1 is implicated in neurodegeneration, cancer, and impaired cellular stress adaptation.

Other names
IP3R1InsP3R1ITPR1Type 1 inositol 1,4,5-trisphosphate receptorInositol trisphosphate receptor type 1
02

Mechanism of action

For antagonists: - Blockade of ligand-gated calcium release from the endoplasmic reticulum. - Inhibition of IP3 binding prevents Ca2+ release into the cytoplasm.

03

Biological functions

Signal transductionCalcium release from endoplasmic reticulumRegulation of intracellular Ca2+ signalsApoptosisAutophagyCellular homeostasis
04

Disease associations

Neurodegenerative diseaseCancerCardiovascular diseaseCellular stress response
05

Safety considerations

Modulation of IP3R1 can disrupt global cellular Ca2+ homeostasis.Excess inhibition can trigger widespread defects in physiological Ca2+ signaling, impacting cell viability.Risk of adverse effects in tissues dependent on tightly regulated Ca2+ signals (e.g., heart, brain).
06

Interacting drugs

Xestospongin B

2 more in the full profile.

07

Biomarkers

Elevated IP3R1 expression is associated with certain cancers and neurodegenerative disorders.IP3R1 protein levels (detected by immunohistochemistry or Western blot) can be used as a biomarker in specific disease contexts.

Beyond the preview

Go deeper on Inositol 1,4,5-trisphosphate receptor 1 (IP3R1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inositol 1,4,5-trisphosphate receptor 1 (IP3R1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call